Skip to main content
. 2022 Jul 7;28(25):2802–2822. doi: 10.3748/wjg.v28.i25.2802

Table 1.

Different gastrointestinal symptoms in coronavirus disease 2019 patients

SI. No.
Total number of human subjects involved in study
Demographics of the study populations
Vomiting
Diarrhea
Nausea
Remarks/study summary
Ref.
1 191 Adults (46-67 years) hospitalised, Chinese peoples, 91 patients having comorbidity 7 (3.7%) 9 (4.7%) 7 (3.7%) Identification of several risk factors and a detailed clinical course of illness for mortality of COVID-19 patients [121]
2 171 Minor aged (1 d-15 years, hospitalised, Chinese children, no such comorbidity 11 (6.4%) 15 (8.8%) NA Report of a spectrum of illness from children infected with SARS-CoV-2 virus [122]
3 1099 Median age group (35-58 years), hospitalised, Chinese patients without any comorbidity 55 (5.0%) 42 (3.8%) 55 (5.0%) Identification and definition of clinical characteristics and disease severity of hospitalized COVID-19 patients [37]
4 140 Adults (25-87 year), hospitalised Chinese patients with high comorbidity 7 (5.0%) 18 (12.9%) 24 (17.3%) Report on hospitalized patients having COVID-19 with abnormal clinical manifestations (fever, fatigue, gastrointestinal symptoms, allergy) [123]
5 73 Adults hospitalised Chinese patients, comorbidity reported NA 26 (35.6%) NA Clinical significance of SARS-CoV-2 by examining viral RNA in feces of COVID-19 patients during hospitalizations [124]
6 52 Adults (mean age 59.7 year), critically ill ICU- admitted Chinese patients, comorbidity reported 2 (3.8%) NA NA Retrospective, single-centered, observational study on critically ill, ICU-admitted adult COVID-19 patients [125]
7 138 Adult (median age 56 years), hospitalised Chinese patients with comorbidities 5 (3.6%) 14 (10.1%) 14 (10.1%) Clinical characteristics of COVID-19 patients in hospitalized conditions [126]
8 41 Middle age group (41-58 years) hospitalised Chinese patients with comorbidities NA 1 (2.6%) NA Epidemiological, laboratory, clinical, and radiological features and treatment with clinical outcomes of hospitalized COVID-19 patients [46]
9 62 Studied patients (median age 41 years) were hospitalised, Chinese ethnicity and comorbidity reported NA 3 (4.8%) NA Most common symptoms at onset of illness with clinical data in confirmed COVID-19 patients [127]
10 137 Studied patients ( mean age 57-55) ware Chinese and hospitalised, comorbidity was also noted NA 11 (8%) NA Investigation of epidemiological history, clinical characteristics, treatment, and prognosis of COVID-19 patients [128]
11 81 Chinese patients (mean age was 49.5 years), hospitalised with high comorbidities 4 (4.9%) 3 (3.7%) NA Report of confirmed COVID-19 patients with chest computer tomography imaging anomalies [129]
12 99 Hospitalised, Chinese patients (average age of the patients was 55.5 years), comorbidity was reported 1 (1%) 2 (2.0%) 1 (1%) Inclusive exploration of epidemiology and clinical features of COVID-19 patients [130]

NA: Not available; ICU: Intensive care unit; COVID-19: Coronavirus disease 2019; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.